Eagle Pharmaceuticals inc (EGRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EGRX Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Eagle Pharmaceuticals inc's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent15.35
Cash & Short-term Investments15.00
Accounts receivable115.14
Inventories42.48
Other Current Assets0.00
Prepaid Expense And Other Assets Current14.27
Total Current Assets187.25
Equipment/Property/Plant Net1.01
Goodwill net45.03
Intangible Assets107.41
Other Assets, Noncurrent34.00
Deferred Income Tax Assets Net30.72
Total Assets404.82
Liabilities
Accounts Payable, Current AC15.84
Accrued Liabilities And Other Liabilities62.49
Long-term Debt, Current Maturities LO8.30
Other Liabilities, Current0.00
Total Current Liabilities86.63
Long-term debt61.90
Total Long-term Debt61.90
Other liabilities, Noncurrent4.26
Deferred Income Tax Liabilities Net-
Total Liabilities152.78
Stockholders' Equity
Treasury Stock Common Value-243.12
Common Stock Value0.02
Treasury Stock Value0.00
Additional Paid In Capital Common Stock373.83
Retained Earnings / Accumulated Deficit122.42
Other Equity-1.11
Common Stockholder's Equity252.04
Total Stockholder's Equity252.04
Liabilities & Stockholder's Equity404.82
4 historic quarters locked

Sign in to unlock the full Eagle Pharmaceuticals inc balance sheet history.

About Eagle Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000827871-23-000024

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.